In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and characterization services including structure analysis, physicochemical properties, biological activity, immunochemical properties and purity and impurities determination to ensure the quality and consistency of your product. Creative Proteomics can fully characterize any protein biopharmaceuticals for the Chemistry and Manufacturing Controls (CMC) section of Investigational New Drug applications (INDs), New Drug Applications (NDAs) and Biologic License Applications (BLAs).